Neurodegeneration and early lethality in superoxide dismutase 2-deficient mice: A comprehensive analysis of the central and peripheral nervous systems

Neuroscience

Volumn 212, Issue , 2012, Pages 201-213

  Oh, S S ^a   Sullivan, K A ^a   Wilkinson, J E ^b   Backus, C ^a   Hayes, J M ^a   Sakowski, S A ^a   Feldman, E L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

BKS.db db mice; Diabetic neuropathy; Nervous system; Oxidative stress; ROS; SOD2

Indexed keywords

MYELIN; NESTIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENZYME DEFICIENCY; GAIT DISORDER; GENE; GENE DELETION; LETHALITY; MOUSE; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVE; PERIPHERAL NERVOUS SYSTEM; PRION DISEASE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; SCIATIC NERVE; SEIZURE; SOD2 GENE; SPINAL CORD; SPINAL GANGLION; SUPEROXIDE DISMUTASE 2 DEFICIENCY; SURAL NERVE;

ANIMALS; CENTRAL NERVOUS SYSTEM; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; FEMALE; GANGLIA, SPINAL; GENES, LETHAL; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NERVE DEGENERATION; PERIPHERAL NERVOUS SYSTEM; SUPEROXIDE DISMUTASE;

EID: 84861663194     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.03.026     Document Type: Article

References (47)

1. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat Med 2004, 10(Suppl.):S18-S25.
2. Andreassen O.A., Ferrante R.J., Klivenyi P., Klein A.M., Shinobu L.A., Epstein C.J., Beal M.F. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis. Ann Neurol 2000, 47:447-455.
3. Histotechnology: a self instructional text 2009, American Society for Clinical Pathology Press, Chicago, IL. F.L. Carson, C. Hladik (Eds.).
4. Cheng H.L., Sullivan K.A., Feldman E.L. Immunohistochemical localization of insulin-like growth factor binding protein-5 in the developing rat nervous system. Brain Res Dev Brain Res 1996, 92:211-218.
5. Dahlstrand J., Lardelli M., Lendahl U. Nestin mRNA expression correlates with the central nervous system progenitor cell state in many, but not all, regions of developing central nervous system. Brain Res Dev Brain Res 1995, 84:109-129.
6. Edwards J.L., Quattrini A., Lentz S.I., Figueroa-Romero C., Cerri F., Backus C., Hong Y., Feldman E.L. Diabetes regulates mitochondrial biogenesis and fission in mouse neurons. Diabetologia 2010, 53:160-169.
7. Elchuri S., Oberley T.D., Qi W., Eisenstein R.S., Jackson Roberts L., Van Remmen H., Epstein C.J., Huang T.T. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 2005, 24:367-380.
8. Feldman E.L. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. J Clin Invest 2003, 111:431-433.
9. Flynn J.M., Choi S.W., Day N.U., Gerencser A.A., Hubbard A., Melov S. Impaired spare respiratory capacity in cortical synaptosomes from Sod2 null mice. Free Radic Biol Med 2011, 50:866-873.
10. Guo Z.M., Xu K., Yue Y., Huang B., Deng X.Y., Zhong N.Q., Hong X., Chen X.G., Xiao D. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system. Acta Biochim Biophys Sin (Shanghai) 2005, 37:133-138.
11. Huang T.T., Carlson E.J., Kozy H.M., Mantha S., Goodman S.I., Ursell P.C., Epstein C.J. Genetic modification of prenatal lethality and dilated cardiomyopathy in Mn superoxide dismutase mutant mice. Free Radic Biol Med 2001, 31:1101-1110.
12. Ikegami T., Suzuki Y., Shimizu T., Isono K., Koseki H., Shirasawa T. Model mice for tissue-specific deletion of the manganese superoxide dismutase (MnSOD) gene. Biochem Biophys Res Commun 2002, 296:729-736.
13. Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 2009, 187:761-772.
14. Kim B., Backus C., Oh S., Hayes J.M., Feldman E.L. Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology 2009, 150:5294-5301.
15. Kuwahara H., Horie T., Ishikawa S., Tsuda C., Kawakami S., Noda Y., Kaneko T., Tahara S., Tachibana T., Okabe M., Melki J., Takano R., Toda T., Morikawa D., Nojiri H., Kurosawa H., Shirasawa T., Shimizu T. Oxidative stress in skeletal muscle causes severe disturbance of exercise activity without muscle atrophy. Free Radic Biol Med 2010, 48:1252-1262.
16. Leinninger G.M., Edwards J.L., Lipshaw M.J., Feldman E.L. Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy. Nat Clin Pract 2006, 2:620-628.
17. Li Y., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., Noble L.J., Yoshimura M.P., Berger C., Chan P.H., Wallace D.C., Epstein C.J. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995, 11:376-381.
18. Lothian C., Lendahl U. An evolutionarily conserved region in the second intron of the human nestin gene directs gene expression to CNS progenitor cells and to early neural crest cells. Eur J Neurosci 1997, 9:452-462.
19. Lustgarten M.S., Jang Y.C., Liu Y., Qi W., Qin Y., Dahia P.L., Shi Y., Bhattacharya A., Muller F.L., Shimizu T., Shirasawa T., Richardson A., Van Remmen H. MnSOD deficiency results in elevated oxidative stress and decreased mitochondrial function but does not lead to muscle atrophy during aging. Aging Cell 2011, 10:493-505.
20. Melov S., Coskun P., Patel M., Tuinstra R., Cottrell B., Jun A.S., Zastawny T.H., Dizdaroglu M., Goodman S.I., Huang T.T., Miziorko H., Epstein C.J., Wallace D.C. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci USA 1999, 96:846-851.
21. Melov S., Doctrow S.R., Schneider J.A., Haberson J., Patel M., Coskun P.E., Huffman K., Wallace D.C., Malfroy B. Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J Neurosci Official J Soc Neurosci 2001, 21:8348-8353.
22. Melov S., Schneider J.A., Day B.J., Hinerfeld D., Coskun P., Mirra S.S., Crapo J.D., Wallace D.C. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet 1998, 18:159-163.
23. Misawa H., Nakata K., Matsuura J., Moriwaki Y., Kawashima K., Shimizu T., Shirasawa T., Takahashi R. Conditional knockout of Mn superoxide dismutase in postnatal motor neurons reveals resistance to mitochondrial generated superoxide radicals. Neurobiol Dis 2006, 23:169-177.
24. Montelius A., Marmigere F., Baudet C., Aquino J.B., Enerback S., Ernfors P. Emergence of the sensory nervous system as defined by Foxs1 expression. Differentiation 2007, 75:404-417.
25. Moreira P.I., Zhu X., Wang X., Lee H.G., Nunomura A., Petersen R.B., Perry G., Smith M.A. Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta 2010, 1802:212-220.
26. Naoi M., Maruyama W., Yi H., Inaba K., Akao Y., Shamoto-Nagai M. Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival. J Neural Transm 2009, 116:1371-1381.
27. Nojiri H., Shimizu T., Funakoshi M., Yamaguchi O., Zhou H., Kawakami S., Ohta Y., Sami M., Tachibana T., Ishikawa H., Kurosawa H., Kahn R.C., Otsu K., Shirasawa T. Oxidative stress causes heart failure with impaired mitochondrial respiration. J Biol Chem 2006, 281:33789-33801.
28. Parajuli N., Marine A., Simmons S., Saba H., Mitchell T., Shimizu T., Shirasawa T., Macmillan-Crow L.A. Generation and characterization of a novel kidney-specific manganese superoxide dismutase knockout mouse. Free Radic Biol Med 2011, 51:406-416.
29. Ray J., Gage F.H. Gene transfer into established and primary fibroblast cell lines: comparison of transfection methods and promoters. Biotechniques 1992, 13:598-603.
30. Ray M.K., Fagan S.P., Brunicardi F.C. The Cre-loxP system: a versatile tool for targeting genes in a cell- and stage-specific manner. Cell Transplant 2000, 9:805-815.
31. Rebelo S., Reguenga C., Osorio L., Pereira C., Lopes C., Lima D. DRG11 immunohistochemical expression during embryonic development in the mouse. Dev Dyn Official Pub Am Assoc Anatomists 2007, 236:2653-2660.
32. Russell J.W., Berent-Spillson A., Vincent A.M., Freimann C.L., Sullivan K.A., Feldman E.L. Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol Dis 2008, 30:420-429.
33. Russell J.W., Golovoy D., Vincent A.M., Mahendru P., Olzmann J.A., Mentzer A., Feldman E.L. High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 2002, 16:1738-1748.
34. Saito T., Greenwood A., Sun Q., Anderson D.J. Identification by differential RT-PCR of a novel paired homeodomain protein specifically expressed in sensory neurons and a subset of their CNS targets. Mol Cell Neurosci 1995, 6:280-292.
35. Sasaki T., Shimizu T., Koyama T., Sakai M., Uchiyama S., Kawakami S., Noda Y., Shirasawa T., Kojima S. Superoxide dismutase deficiency enhances superoxide levels in brain tissues during oxygenation and hypoxia-reoxygenation. J Neurosci Res 2011, 89:601-610.
36. Schon E.A., Przedborski S. Mitochondria: the next (neurode)generation. Neuron 2011, 70:1033-1053.
37. Shimizu T., Nojiri H., Kawakami S., Uchiyama S., Shirasawa T. Model mice for tissue-specific deletion of the manganese superoxide dismutase gene. Geriatr Gerontol Int 2010, 10(Suppl. 1):S70-79.
38. Sullivan K.A., Feldman E.L. Immunohistochemical localization of insulin-like growth factor-II (IGF-II) and IGF-binding protein-2 during development in the rat brain. Endocrinology 1994, 135:540-547.
39. Sullivan K.A., Hayes J.M., Wiggin T.D., Backus C., Su Oh.S., Lentz S.I., Brosius F., Feldman E.L. Mouse models of diabetic neuropathy. Neurobiol Dis 2007, 28:276-285.
40. Tronche F., Kellendonk C., Kretz O., Gass P., Anlag K., Orban P.C., Bock R., Klein R., Schutz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 1999, 23:99-103.
41. Vincent A.M., Hayes J.M., McLean L.L., Vivekanandan-Giri A., Pennathur S., Feldman E.L. Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes 2009, 58:2376-2385.
42. Vincent A.M., McLean L.L., Backus C., Feldman E.L. Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J 2005, 19:638-640.
43. Vincent A.M., Russell J.W., Low P., Feldman E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 2004, 25:612-628.
44. Vincent A.M., Russell J.W., Sullivan K.A., Backus C., Hayes J.M., McLean L.L., Feldman E.L. SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy. Exp Neurol 2007, 208:216-227.
45. Wiggin T.D., Sullivan K.A., Pop-Busui R., Amato A., Sima A.A., Feldman E.L. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 2009, 58:1634-1640.
46. Yu T.S., Dandekar M., Monteggia L.M., Parada L.F., Kernie S.G. Temporally regulated expression of Cre recombinase in neural stem cells. Genesis 2005, 41:147-153.
47. Yu Y., Bradley A. Engineering chromosomal rearrangements in mice. Nat Rev Genet 2001, 2:780-790.